Jianan Gong 31st Lorne Cancer Conference 2019

Abstracts this author is presenting:

• Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia — Poster Session I